|
**Overview**: Allergy Asthma Rhinitis Pediatric Panel**Introduction**: The Allergy Asthma Rhinitis Pediatric Panel is a diagnostic tool designed to screen for asthma and rhinitis allergens in children using serum samples. In India, allergic rhinitis affects approximately 22-23.5 percent of adolescents according to ISAAC and recent multicentric studies, while childhood asthma contributes significantly to the national burden of 37.5 million total asthma cases. Sensitization to common indoor allergens like house dust mite (47-70 percent in pediatric cohorts) and cockroach (18-40 percent) is dominant, with pollen and mold varying regionally due to seasonal and climatic factors. Urban pollution, overcrowding, and poor ventilation in low-SES households exacerbate symptoms including wheezing, persistent sneezing, nasal congestion, eye itching, and recurrent respiratory infections. High morbidity arises from underdiagnosis in school-going children, limited access to allergy specialists in rural and semi-urban areas, and delayed management leading to school absenteeism and reduced quality of life. Per ICMR-aligned immunology guidelines, the test employs immunoassay for detailed parameter analysis over 1-2 days with high sensitivity and specificity, making it valuable for early identification of triggers in children with persistent respiratory symptoms. This diagnostic falls under pediatric allergy screening and targets children with suspected asthma or rhinitis, addressing the challenge of accurate allergen detection to guide environmental control, pharmacotherapy, and potential immunotherapy. With elevated morbidity due to underdiagnosis in pediatric populations, the test supports public health efforts by enabling precise identification, facilitating management, and reducing long-term complications such as growth impairment or severe exacerbations. Its serum-based approach ensures reliable detection even in resource-limited pediatric clinics across India.**Other Names**: Asthma Ped Pnl.**FDA Status**: FDA approved, CLIA certified for immunology, compliant with 2025 standards.**Historical Milestone**: Expanded with specific IgE testing; in India, gained relevance with rising pediatric allergic disease prevalence documented in ISAAC phases.**Purpose**: The test screens for 9 parameters including total IgE to guide assessment, identify major triggers, and inform treatment and prevention strategies in pediatric populations.**Test Parameters**: 1. Total IgE, 2. House Dust Mite IgE, 3. Grass Pollen IgE, 4. Tree Pollen IgE, 5. Weed Pollen IgE, 6. Mold IgE, 7. Cat Dander IgE, 8. Dog Dander IgE, 9. Food Mix IgE.**Pretest Condition**: No fasting required; parents should report wheezing, sneezing, nasal congestion, eye itching, or recurrent respiratory symptoms in the child.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Parents should provide details on child's symptoms, frequency of exacerbations, home environment (pets, dust, mold), diet, family history of atopy, or school absenteeism due to illness.**Consent**: Written informed consent is required from parent/guardian, detailing the test's purpose, potential risks of untreated allergic conditions including recurrent infections or poor school performance, benefits of early detection, and minimal discomfort from venipuncture.**Procedural Considerations**: The test involves sample processing using immunoassay by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols, and store kits according to manufacturer specifications to ensure reliability.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis, or concurrent viral infections common in children can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Abnormal results indicate possible allergic triggers, necessitating further investigation like specialist consultation or additional testing. Normal results may require follow-up if symptoms persist.**Specialist Consultation**: Pediatricians, pediatric allergists, or pulmonologists should be consulted for case management, treatment planning, and coordination with school health programs.**Additional Supporting Tests**: Spirometry, nasal endoscopy, or home allergen assessment for confirmation.**Test Limitations**: The test may produce false negatives in low exposure periods or false positives in sensitization without clinical disease, requiring a comprehensive diagnostic approach that includes clinical correlation.**References**: ICMR Pediatric Allergy Guidelines 2023, Indian Journal of Pediatrics 2024, ISAAC India Studies 2023-2025. |
